SCHEMBL300186

SCHEMBL300186

CCCCCCCCCCCCC(S)CC(C)(c1cc(C(C)(C)C)c(O)cc1C)c1cc(C(C)(C)C)c(O)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.47
TP53 P04637 2/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HIF1A Q16665 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
ATP2A2 P16615 1/20 0.35
ATP2A3 Q93084 1/20 0.35
GAA P10253 1/20 0.34
XBP1 P17861 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25366811 0.81 ALOX15 (0.44) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL6793734 0.81 ALOX15 (0.47) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL29421162 0.79 ALOX15 (0.46) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL78065 0.79 ALOX15 (0.46) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL9249702 0.77 ALOX15 (0.61) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL1271077 0.77 ALOX15 (0.47) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL5202313 0.77 ALOX15 (0.50) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL5202307 0.76 ALOX15 (0.46) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL11904870 0.76 ALOX15 (0.49) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL5086034 0.74 ALOX15 (0.78) ALOX15TP53CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1857506-B1 Oxidation stable iron oxide pigments, method for their production and their use. LANXESS DEUTSCHLAND GMBH (DE) 2017-07-12 EP claimed
US-20260071126-A1 Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film MERCK PATENT GMBH (DE) 2026-03-12 US disclosed
US-12570900-B2 Polymerisable compound, polymerisable LC material and polymer film MERCK PATENT GMBH (DE) 2026-03-10 US disclosed
US-12565617-B2 Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film MERCK PATENT GMBH (DE) 2026-03-03 US disclosed
US-20250361445-A1 POLYMERISABLE LIQUID CRYSTAL MEDIUM AND POLYMERISED LIQUID CRYSTAL FILM MERCK PATENT GMBH (DE) 2025-11-27 US disclosed
EP-4590786-A1 POLYMERISABLE LIQUID CRYSTAL MEDIUM AND POLYMERISED LIQUID CRYSTAL FILM Merck Patent GmbH (DE) 2025-07-30 EP disclosed
EP-4217442-B1 POLYMERIZABLE LIQUID CRYSTAL MATERIAL AND POLYMERIZED LIQUID CRYSTAL FILM MERCK PATENT GMBH (DE) 2025-06-18 EP disclosed
US-12325806-B2 Photocurable composition for use in 3D printing BASF SE (DE) 2025-06-10 US disclosed
EP-4536775-A1 POLYMERISABLE LIQUID CRYSTAL MEDIUM AND POLYMERISED LIQUID CRYSTAL FILM Merck Patent GmbH (DE) 2025-04-16 EP disclosed
US-12187946-B2 Polymerisable liquid crystal material and polymerised liquid crystal film MERCK PATENT GMBH (DE) 2025-01-07 US disclosed
EP-0311568-B1 LONG CHAIN N-ALYKL-ALPHA-ALKYL NITRONES AND THEIR USE AS STABILIZERS CIBA-GEIGY AG (CH) 1991-09-04 EP disclosed
EP-0323409-A2 Polyolefin compositions stabilized with long chain N,N-dialkylhydroxylamines CIBA-GEIGY AG (CH) 1989-07-05 EP disclosed
US-4830714-A Process for the production of printed circuit boards BAYER AKTIENGESELLSCHAFT (DE) 1989-05-16 US disclosed
EP-0311568-A2 Long chain N-alykl-alpha-alkyl nitrones and their use as stabilizers CIBA-GEIGY AG (CH) 1989-04-12 EP disclosed
US-4568571-A Process for the adhesion-activation of polyamide substrates for electroless metallization BAYER AKTIENGESELLSCHAFT (DE) 1986-02-04 US disclosed
US-4554183-A Process for pretreating polyamide substrates for electroless metallization BAYER AKTIENGESELLSCHAFT (DE) 1985-11-19 US disclosed
US-4322374-A 2,4,4,4-Tetrahalobutanoic acid halide CIBA-GEIGY CORPORATION (US) 1982-03-30 US disclosed
US-4242278-A Process for the preparation of 2-(2',2',2'-trihalogenoethyl)-4-halogenocyclobutan-1-ones CIBA-GEIGY CORPORATION (US) 1980-12-30 US disclosed
US-4061644-A FROM A FURAN AND AMMONIA CIBA-GEIGY CORPORATION (US) 1977-12-06 US disclosed
US-4056544-A Anthraquinone compounds BAYER AKTIENGESELLSCHAFT (DT) 1977-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570900-B2 Polymerisable compound, polymerisable LC material and polymer film L3MBTL3, L3MBTL1, L3MBTL4 ALOX15 2261/4885TP53 963/4885CYP2D6 2058/4885
US-20260071126-A1 Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film MLX, SCO2, VCL ALOX15 2042/4885TP53 1510/4885CYP2D6 2967/4885
US-12565617-B2 Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film NOD1, OSTC, MLX ALOX15 1446/4885TP53 2690/4885CYP2D6 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.